BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28941354)

  • 21. Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.
    Shanmuganathan B; Sheeja Malar D; Sathya S; Pandima Devi K
    PLoS One; 2015; 10(11):e0141708. PubMed ID: 26536106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer's disease.
    McCarthy AD; Owens IJ; Bansal AT; McTighe SM; Bussey TJ; Saksida LM
    Pharmacol Biochem Behav; 2011 Mar; 98(1):76-80. PubMed ID: 21130801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
    Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N
    Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes.
    Sağlık BN; Ilgın S; Özkay Y
    Eur J Med Chem; 2016 Nov; 124():1026-1040. PubMed ID: 27783974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
    Luo Z; Sheng J; Sun Y; Lu C; Yan J; Liu A; Luo HB; Huang L; Li X
    J Med Chem; 2013 Nov; 56(22):9089-99. PubMed ID: 24160297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors.
    Hu Y; Zhang J; Chandrashankra O; Ip FC; Ip NY
    Bioorg Med Chem; 2013 Feb; 21(3):676-83. PubMed ID: 23273608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling donepezil template into multipotent hybrids with antioxidant properties.
    Mezeiova E; Spilovska K; Nepovimova E; Gorecki L; Soukup O; Dolezal R; Malinak D; Janockova J; Jun D; Kuca K; Korabecny J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):583-606. PubMed ID: 29529892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
    Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.
    Sugimoto H; Yamanishi Y; Iimura Y; Kawakami Y
    Curr Med Chem; 2000 Mar; 7(3):303-39. PubMed ID: 10637367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of donepezil hydrochloride (Aricept) for the treatment of Alzheimer's disease].
    Yamanishi Y; Ogura H; Kosasa T
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1047-51. PubMed ID: 10771671
    [No Abstract]   [Full Text] [Related]  

  • 37. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L; Miao H; Sun Y; Meng F; Li X
    Eur J Med Chem; 2014 Nov; 87():429-39. PubMed ID: 25282266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
    Anand P; Singh B
    Bioorg Med Chem; 2012 Jan; 20(1):521-30. PubMed ID: 22172310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
    Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
    Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.